US Stock MarketDetailed Quotes

INSTITUTE BIOMEDICAL RESH CORP (MRES)

Watchlist
  • 0.0021
  • 0.00000.00%
15min DelayClose Apr 10 15:59 ET
5.68MMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INSTITUTE BIOMEDICAL RESH CORP (MRES) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2010
(Q2)Sep 30, 2010
(Q1)Jun 30, 2010
(FY)Mar 31, 2010
(Q4)Mar 31, 2010
(Q3)Dec 31, 2009
(Q2)Sep 30, 2009
(Q1)Jun 30, 2009
(FY)Mar 31, 2009
(Q4)Mar 31, 2009
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
0
0
0
0
0
0
0
0
Gross profit
0
0
0
0
0
0
0
0
0
0
Operating expense
-81.59%18.11K
94.19%35.96K
178,526.22%52.22M
-38.68%261.73K
-22.07%115.58K
15.38%98.4K
-79.44%18.52K
-71.66%29.24K
-89.54%426.8K
6.56%148.31K
Selling and administrative expenses
-94.09%5.18K
83.71%23.02K
2,326.53%552.28K
-38.69%231.81K
-14.19%108.82K
15.18%87.7K
-84.24%12.53K
-76.21%22.76K
-90.36%378.12K
22.68%126.82K
-Selling and marketing expense
--0
----
--0
-77.73%888
--888
--0
----
--0
-91.04%3.99K
--0
-General and administrative expense
-94.09%5.18K
----
2,326.53%552.28K
-38.28%230.93K
-14.89%107.93K
15.18%87.7K
----
-76.21%22.76K
-90.35%374.14K
25.60%126.82K
Research and development costs
--0
--0
--0
-64.49%7.34K
--0
253.61%5K
-67.40%922
--1.41K
-86.02%20.66K
-38.68%16.42K
Depreciation amortization depletion
126.97%12.93K
155.49%12.93K
1,020,660.25%51.67M
-19.41%22.58K
33.04%6.75K
-26.25%5.7K
-34.50%5.06K
-32.37%5.06K
148.29%28.01K
-43.86%5.08K
-Depreciation and amortization
----
----
1,020,660.25%51.67M
-19.41%22.58K
----
----
----
-32.37%5.06K
148.29%28.01K
-43.86%5.08K
Operating profit
81.59%-18.11K
-94.19%-35.96K
-178,526.22%-52.22M
38.68%-261.73K
22.07%-115.58K
-15.38%-98.4K
79.44%-18.52K
71.66%-29.24K
91.99%-426.8K
89.32%-148.31K
Net non-operating interest income expense
-934.24%-37.57K
-1,435.81%-40.96K
-534.22%-15.01K
29.21%-11.68K
-76.69%-3.01K
41.70%-3.63K
46.55%-2.67K
33.66%-2.37K
53.74%-16.49K
91.57%-1.7K
Non-operating interest expense
934.24%37.57K
1,435.81%40.96K
534.22%15.01K
-29.21%11.68K
76.69%3.01K
-41.70%3.63K
--2.67K
--2.37K
-53.74%16.49K
--1.7K
Other net income (expense)
2.16M
Special income (charges)
--0
--0
--2.16M
--0
--0
--0
--0
--0
--0
----
-Less：Restructuring and merger&acquisition
--0
--0
---2.16M
--0
--0
--0
--0
--0
--0
----
Income before tax
45.42%-55.69K
-263.10%-76.92K
-158,371.31%-50.08M
38.32%-273.4K
20.95%-118.58K
-11.49%-102.03K
77.72%-21.18K
70.39%-31.6K
91.74%-443.29K
5.88%-150.02K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
45.42%-55.69K
-263.10%-76.92K
-158,371.31%-50.08M
38.32%-273.4K
20.95%-118.58K
-11.49%-102.03K
77.72%-21.18K
70.39%-31.6K
91.74%-443.29K
5.88%-150.02K
Net income continuous Operations
45.42%-55.69K
-263.10%-76.92K
-158,371.31%-50.08M
38.32%-273.4K
20.95%-118.58K
-11.49%-102.03K
77.72%-21.18K
70.39%-31.6K
91.74%-443.29K
5.88%-150.02K
Net income discontinuous operations
----
----
----
--0
----
----
----
----
--0
----
Minority interest income
Net income attributable to the parent company
45.42%-55.69K
-263.10%-76.92K
-158,371.31%-50.08M
38.32%-273.4K
20.95%-118.58K
-11.49%-102.03K
77.72%-21.18K
70.39%-31.6K
91.74%-443.29K
5.88%-150.02K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
45.42%-55.69K
-263.10%-76.92K
-158,371.31%-50.08M
38.32%-273.4K
20.95%-118.58K
-11.49%-102.03K
77.72%-21.18K
70.39%-31.6K
91.74%-443.29K
5.88%-150.02K
Basic earnings per share
0
0
-10,400.00%-1.05
0.00%-0.1
-152.02%-0.07
-0.02
0
-0.01
94.74%-0.1
-0.0278
Diluted earnings per share
0
0
-10,400.00%-1.05
0.00%-0.1
-152.02%-0.07
-0.02
0
-0.01
94.74%-0.1
35.10%-0.0278
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Dec 31, 2010(Q2)Sep 30, 2010(Q1)Jun 30, 2010(FY)Mar 31, 2010(Q4)Mar 31, 2010(Q3)Dec 31, 2009(Q2)Sep 30, 2009(Q1)Jun 30, 2009(FY)Mar 31, 2009(Q4)Mar 31, 2009
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0000000000
Gross profit 0000000000
Operating expense -81.59%18.11K94.19%35.96K178,526.22%52.22M-38.68%261.73K-22.07%115.58K15.38%98.4K-79.44%18.52K-71.66%29.24K-89.54%426.8K6.56%148.31K
Selling and administrative expenses -94.09%5.18K83.71%23.02K2,326.53%552.28K-38.69%231.81K-14.19%108.82K15.18%87.7K-84.24%12.53K-76.21%22.76K-90.36%378.12K22.68%126.82K
-Selling and marketing expense --0------0-77.73%888--888--0------0-91.04%3.99K--0
-General and administrative expense -94.09%5.18K----2,326.53%552.28K-38.28%230.93K-14.89%107.93K15.18%87.7K-----76.21%22.76K-90.35%374.14K25.60%126.82K
Research and development costs --0--0--0-64.49%7.34K--0253.61%5K-67.40%922--1.41K-86.02%20.66K-38.68%16.42K
Depreciation amortization depletion 126.97%12.93K155.49%12.93K1,020,660.25%51.67M-19.41%22.58K33.04%6.75K-26.25%5.7K-34.50%5.06K-32.37%5.06K148.29%28.01K-43.86%5.08K
-Depreciation and amortization --------1,020,660.25%51.67M-19.41%22.58K-------------32.37%5.06K148.29%28.01K-43.86%5.08K
Operating profit 81.59%-18.11K-94.19%-35.96K-178,526.22%-52.22M38.68%-261.73K22.07%-115.58K-15.38%-98.4K79.44%-18.52K71.66%-29.24K91.99%-426.8K89.32%-148.31K
Net non-operating interest income expense -934.24%-37.57K-1,435.81%-40.96K-534.22%-15.01K29.21%-11.68K-76.69%-3.01K41.70%-3.63K46.55%-2.67K33.66%-2.37K53.74%-16.49K91.57%-1.7K
Non-operating interest expense 934.24%37.57K1,435.81%40.96K534.22%15.01K-29.21%11.68K76.69%3.01K-41.70%3.63K--2.67K--2.37K-53.74%16.49K--1.7K
Other net income (expense) 2.16M
Special income (charges) --0--0--2.16M--0--0--0--0--0--0----
-Less：Restructuring and merger&acquisition --0--0---2.16M--0--0--0--0--0--0----
Income before tax 45.42%-55.69K-263.10%-76.92K-158,371.31%-50.08M38.32%-273.4K20.95%-118.58K-11.49%-102.03K77.72%-21.18K70.39%-31.6K91.74%-443.29K5.88%-150.02K
Income tax 0000000000
Net income 45.42%-55.69K-263.10%-76.92K-158,371.31%-50.08M38.32%-273.4K20.95%-118.58K-11.49%-102.03K77.72%-21.18K70.39%-31.6K91.74%-443.29K5.88%-150.02K
Net income continuous Operations 45.42%-55.69K-263.10%-76.92K-158,371.31%-50.08M38.32%-273.4K20.95%-118.58K-11.49%-102.03K77.72%-21.18K70.39%-31.6K91.74%-443.29K5.88%-150.02K
Net income discontinuous operations --------------0------------------0----
Minority interest income
Net income attributable to the parent company 45.42%-55.69K-263.10%-76.92K-158,371.31%-50.08M38.32%-273.4K20.95%-118.58K-11.49%-102.03K77.72%-21.18K70.39%-31.6K91.74%-443.29K5.88%-150.02K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 45.42%-55.69K-263.10%-76.92K-158,371.31%-50.08M38.32%-273.4K20.95%-118.58K-11.49%-102.03K77.72%-21.18K70.39%-31.6K91.74%-443.29K5.88%-150.02K
Basic earnings per share 00-10,400.00%-1.050.00%-0.1-152.02%-0.07-0.020-0.0194.74%-0.1-0.0278
Diluted earnings per share 00-10,400.00%-1.050.00%-0.1-152.02%-0.07-0.020-0.0194.74%-0.135.10%-0.0278
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -